Lynch Archives - CDR – Chain Drug Review

CVS’ first quarter results beat projections

May 4, 2022 by Chain Drug Review CVS, first quarter, Lynch Featured Articles, Leading Headlines, Retail News

WOONSOCKET, R.I. _ CVS Health reported strong first quarter results, topping analysts’ forecasts for revenue and earnings. Total revenue for the period ended March 31 climbed 11.2% from the year-ago quarter to $76.8 billion, driven by growth across all segments. Wall Street had estimated revenue of $75.3 billion. Adjusted earnings per share rose 8.8% to

CVS’ Q2 sales and earnings beat forecasts

August 4, 2021 by Chain Drug Review CVS, earnings, Lynch, minimum wage, second quarter Business, Featured Articles, Leading Headlines, Retail News

WOONSOCKET, R.I. — CVS Health posted second quarter sales and earnings that easily topped analysts’ projections. Strong retail sales helped lift the company’s adjusted profit to $2.42 a share, well ahead of Wall Street’s prediction of $2.07 a share. Revenue climbed 11.1% to $72.62 billion, beating the forecast of $70.24 billion. The company boosted its